Back to Awarded Treatment Trials
Awarded Trial: 03-RC-005-4
1 g every 12 hours
Secondary Drug Intervention
Duration of Study Period for Each Subject
The goal was to use valacyclovir, an antiviral, as adjunct medication for 16 weeks for 62 patients with schizophrenia who had antibodies to cytomegalovirus (CMV) in a double-blind, placebo-controlled trial. The patients were chronic, with a mean duration of illness of 25 years. The valacylovir was well tolerated, with no SAE's attributable to the medication. However, there were no significant differences between the groups on PANSS at the end of the study.
Sheppard Pratt Health System Inc.
6501 N. Charles Street, P.O. Box 6815
City or Town
State or Province
Zip or Postal Code